Thursday, May 2, 2013
Ambit Biosciences Sets Estimated IPO Range
San Diego-based Ambit Biosciences has set the estimated range for its IPO, saying in a filing today that it is expecting to offer 4,645,000 shares of its stock at between $13.00 and $15.00 per share. The firm has applied to list on the NASDAQ Global Market as AMBI. Ambit is backed by Apposite Healthcare Fund, Forward Ventures, GIMV, GrowthWorks, MedImmune Ventures, OrbiMed, Perseus-Soros Biopharmaceutical Fund, Roche, and others. The firm filed its initial paperwork for the IPO in February. The offering is being run by Citigroup, Leerink Swann, BMO Capital Markets, and Baird.